SEC Form 4 · accession 0000885590-15-000078
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J. Michael Pearson
Officer — Chief Executive Officer · Director
Period of report
Nov 5, 2015
Accepted (ET)
Nov 9, 2015 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF2 | Nov 5, 2015 | S | 147,054 | $74.67 | D | 2,665,009 | D | |
| Common Stock, no par valueF3 | Nov 5, 2015 | S | 800,345 | $76.66 | D | 1,864,664 | D | |
| Common Stock, no par value | Nov 5, 2015 | S | 350,000 | $84.26 | D | 1,514,664 | D | |
| Common Stock, no par value | holding | — | — | — | 175,000 | I | In Trust by Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were held by Goldman Sachs as collateral to secure Mr. Pearson's obligations under personal loans Mr. Pearson obtained from Goldman Sachs, to, among other things, finance charitable contributions, including a contribution to Duke University, helping to fund a community swimming pool, purchase shares of the issuer, and meet certain tax obligations related to the vesting and payment of compensatory equity awards. On November 5, 2015, Goldman Sachs ordered the sale of these shares in repayment of the loans. After repayment of the loans with the proceeds from the sale by Goldman Sachs, the loan agreements will terminate and there will be no amounts outstanding under those agreements.
- F2The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $74.64 to $74.95. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F3The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $76.34 to $77.25. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.